All that bleeds is not infliximab-refractory ulcerative colitis

J. K. Law, B. Salh, E. M. Yoshida

Research output: Contribution to journalArticlepeer-review


The role of biological agents in moderate to severe ulcerative colitis has been shown to be effective in the induction of clinical remission, However, the role of infliximab therapy for induction of remission in patients with fulminant colitis is debatable. A case of a hospitalized patient with a new diagnosis of severe ulcerative coliris refractory to intravenous steroids is presented. The patient was treated with infliximab and discharged with clinical remission, but subsequently presented back to hospital with a lower gastrointestinal hemorrhage.

Original languageEnglish (US)
Pages (from-to)91-92
Number of pages2
JournalCanadian Journal of Gastroenterology
Issue number2
StatePublished - 2009
Externally publishedYes


  • Infliximab
  • Severe colitis

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'All that bleeds is not infliximab-refractory ulcerative colitis'. Together they form a unique fingerprint.

Cite this